Connolly S J. Preventing stroke in patients with atrial fibrillation: current treatments and new concepts[J]. Am Heart J, 2003, 145(3): 418-423. [2]Blackshear J L, Odell J A. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation[J]. Ann Thorac Surg, 1996, 61(2): 755-759. [3]European heart rhythm association, European association for cardio-thoracic Surgery, Camm A J, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2010, 31(19): 2369-2429. [4]Kopecky S L, Gresh B J, McGoon M D, et al. The natural history of lone atrial fibrillation. A population-based study over three decades[J]. N Engl J Med, 1987, 317(11): 669-674. [5]Reddy V Y, Mobius-Winkler S, Miller M A, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)[J]. J Am Coll Cardiol, 2013, 61(25): 2551-2556. [6]Horstmann S, Zugck C, Krumsdorf U, et al. Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage[J]. Neurology, 2014, 82(2): 135-138. [7]Camm A J, Lip G Y, De-Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association[J]. Eur Heart J, 2012, 33(21): 2719-2747. [8]Kernan W N, Ovbiagele B, Black H R, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(7): 2160-2236.